Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome

NCT03805581 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease
Acute Chest Syndrome

Interventions

DRUG: Defibrotide

Sponsor

New York Medical College

Collaborators

[object Object]